Pharmacotherapy of generalized anxiety disorder: focus and update on pregabalin
C Both, G Kojda… - Expert review of …, 2014 - Taylor & Francis
Generalized anxiety disorder (GAD) is one of the most common psychiatric disorders and
clinically characterized by both psychological anxiety and somatic symptoms (muscular …
clinically characterized by both psychological anxiety and somatic symptoms (muscular …
Biological Perspectives Biological Perspectives: Hydroxyzine for Anxiety: Another Look at an Old Drug.
JS Dowben, JS Grant, KD Froelich… - … in psychiatric care, 2013 - search.ebscohost.com
The article presents an overview of the role that a first generation antihistamine drug called
hydroxyzine can play in alleviating the symptoms of anxiety in patients. A discussion of the …
hydroxyzine can play in alleviating the symptoms of anxiety in patients. A discussion of the …
Effects of chronic fluoxetine treatment on anxious behaviour of BALB/c mice in a 3-dimensional maze
Here we used a 3-dimensional (3D) maze, a modification of the radial maze, to assess the
effects of treatment for two weeks with a single daily dose of fluoxetine (20 mg/kg, ip) on …
effects of treatment for two weeks with a single daily dose of fluoxetine (20 mg/kg, ip) on …
[HTML][HTML] Generalized anxiety disorder in adults: Management
M Craske, A Bystritsky - UpToDate. Accessed September, 2022 - medilib.ir
INTRODUCTION—Generalized anxiety disorder (GAD) is characterized by excessive worry
and anxiety that are difficult to control, cause significant distress and impairment, and occur …
and anxiety that are difficult to control, cause significant distress and impairment, and occur …
Психофармакотерапия тревожных расстройств: современный взгляд на проблему
ИВ Щербакова, ВЮ Крылатых… - Российский …, 2017 - cyberleninka.ru
Статья представляет собой обзор современной литературы, посвященной
фармакологическим способам лечения тревожных расстройств (ТР). Авторы …
фармакологическим способам лечения тревожных расстройств (ТР). Авторы …
[HTML][HTML] Evaluating a dimensional approach to treatment resistance in anxiety disorders: A two-year follow-up study
WA Bokma, NM Batelaan, BWJH Penninx… - Journal of Affective …, 2021 - Elsevier
Background Treatment resistance in anxiety disorders (TR-AD) has been previously defined
by failed priortreatments and by various clinical aspects, but the impact of these aspects on …
by failed priortreatments and by various clinical aspects, but the impact of these aspects on …
A psycho-behavioral perspective on modelling obsessive-compulsive disorder (OCD) in animals: the role of context
DW Wolmarans, DJ Stein… - Current Medicinal …, 2018 - ingentaconnect.com
Obsessive-compulsive disorder is a heterogeneous and debilitating condition, characterized
by intrusive thoughts and compulsive repetition. Animal models of OCD are important tools …
by intrusive thoughts and compulsive repetition. Animal models of OCD are important tools …
Anxiety and anxiety disorders
H Leigh - Handbook of consultation-liaison psychiatry, 2014 - Springer
Anxiety clearly has adaptive value both for the individual and in an evolutionary sense.
Anxiety is considered pathologic if it is uncontrollably excessive or persistent so as to affect …
Anxiety is considered pathologic if it is uncontrollably excessive or persistent so as to affect …
Association Analysis of the Brain-Derived Neurotrophic Factor Gene Val66Met Polymorphism and Gender with Efficacy of Antidepressants in the Chinese Han …
M Lin, J Zhu, Y Yuan, L Ren, M Qian… - Genetic Testing and …, 2018 - liebertpub.com
Background and Aim: This study was designed to explore the relationship between the brain-
derived neurotrophic factor (BDNF) Val66Met polymorphism and antidepressants' efficacy in …
derived neurotrophic factor (BDNF) Val66Met polymorphism and antidepressants' efficacy in …